March 3, 2020 San Diego, CA USA. – Nascent Biotech, Inc. (OTCQB: NBIO), today announced its intention to begin research on a possible treatment for patients infected with the Coronavirus. [...]
Nascent Biotech founder Dr. Mark C. Glassy will once again be organizing and speaking at the Human Antibodies & Hybridomas conference, held 11-13 November 2020, The Richard Doll Building, [...]
Click each link to download individual publications in PDF format. Brain‐derived neurotrophic factor downregulation in gastric cancer Antibody drug conjugates: Progress, pitfalls, and promises [...]
